Concord Wealth Partners’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-139
Closed -$1.56K – 877
2023
Q3
$1.56K Hold
139
– – ﹤0.01% 903
2023
Q2
$1.4K Hold
139
– – ﹤0.01% 913
2023
Q1
$1.31K Hold
139
– – ﹤0.01% 864
2022
Q4
$1.7K Buy
+139
New +$1.73K ﹤0.01% 975
2022
Q3
– Sell
-139
Closed -$3K – 431
2022
Q2
$3K Hold
139
– – ﹤0.01% 929
2022
Q1
$4K Hold
139
– – ﹤0.01% 955
2021
Q4
$4K Hold
139
– – ﹤0.01% 982
2021
Q3
$4K Sell
139
-215
-61% -$7.21K ﹤0.01% 624
2021
Q2
$12K Hold
354
– – ﹤0.01% 590
2021
Q1
$10K Buy
+354
New +$10.9K ﹤0.01% 585

Other funds holding ELAN

Concord Wealth Partners's ELAN Position: Q4 2023 in Review

Concord Wealth Partners sold out of Elanco Animal Health (ELAN) in Q4 2023, closing a stake of 139 shares — an estimated $1.56K sold.

Concord Wealth Partners first reported a position in ELAN in Q1 2021 and held it in 10 quarters. The position peaked at $12K in Q2 2021. 355 funds tracked by Wall St. Rank hold ELAN as of Q4 2023.

  • Concord Wealth Partners reported no remaining Elanco Animal Health position as of Q4 2023 after selling out during the quarter.
  • Concord Wealth Partners sold 139 Elanco Animal Health shares in Q4 2023, an estimated $1.56K.
  • Concord Wealth Partners first reported a position in Elanco Animal Health in Q1 2021 and held it in 10 quarters.
  • Concord Wealth Partners's Elanco Animal Health position peaked at $12K in Q2 2021.
  • 355 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2023.

Based on Concord Wealth Partners's 13F filing for Q4 2023, filed 6 Feb 2024.